Arcede Pharma is a pharmaceutical company. The company conducts research and development in the field of chronic obstructive pulmonary disease, also abbreviated as COPD, and severe asthma. The company's product portfolio includes medicines intended for the treatment and relief of the above ailments. The largest activity is found within the Nordic market. The company was created via a spin-off of Respiratorius in 2022 and today has its headquarters in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Erik Magnusson (tf)

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 14,47 14,47 2023-12-27
Avanza Pension 7,00 7,00 2023-12-27
Ben Hayes 3,01 3,01 2023-12-27
Konsult I Beddingestrand AB 1,78 1,78 2023-12-27
Hans Harvig 1,77 1,77 2023-12-27
Hans Mandahl 1,74 1,74 2023-12-27
Hartmut Wiese 1,69 1,69 2023-12-27
Hans Jönsson 1,69 1,69 2023-12-27
Hampus Svensson 1,40 1,40 2023-12-27
Nordnet Pensionsförsäkring 1,38 1,38 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-05-16 Årsstämma 2023

  • 2024-05-16 Delårsrapport 2024-Q1

  • 2024-08-28 Delårsrapport 2024-Q2

  • 2024-11-25 Delårsrapport 2024-Q3